Health Trials

Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed

ConditionsPeritoneal CarcinomatosisPseudomyxoma PeritoneiPeritoneal Mesothelioma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversitaire Ziekenhuizen KU Leuven

About this trial

The purpose of this study is to register the follow-up data of patients who, because of a peritoneal surface malignancy, will undergo cytoreductive surgery and HIPEC.

Eligibility criteria

Qualifiers

Patients with peritoneal carcinomatosis of colorectal origin, patients with pseudomyxoma peritonei (type DPAM or PMCA) and patients with peritoneal mesothelioma who are planned to undergo cytoreductive surgery and HIPEC because of a peritoneal surface malignancy

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

125 Participants
are grouped into 1 trial group

Sponsors and collaborators

Universitaire Ziekenhuizen KU Leuven

Lead sponsor

Source ClinicalTrials.gov